ACR appropriateness criteria staging and follow-up of ovarian cancer

Journal of the American College of Radiology

Volumn 10, Issue 11, 2013, Pages 822-827

  Mitchell, Donald G ^a   Javitt, Marcia C ^b   Glanc, Phyllis ^c   Bennett, Genevieve L ^d   Brown, Douglas L ^e   Dubinsky, Theodore ^f   Harisinghani, Mukesh G ^g   Harris, Robert D ^h   Horowitz, Neil S ^i,j   Pandharipande, Pari V ^k   Pannu, Harpreet K ^l   Podrasky, Ann E ^m   Royal, Henry D ^n,o   Shipp, Thomas D ^i,o   Siegel, Cary Lynn ⁿ   Simpson, Lynn ^i,q   Wong You Cheong, Jade J ^r   Zelop, Carolyn M ^k,p  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^j Division of Gynecologic Oncology   (United States)

^k BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^l MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^m BAPTIST HOSPITAL OF MIAMI   (United States)

ⁿ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o Society of Nuclear Medicine   (United States)

^p AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS   (United States)

^q Howard Hughes Medical Institute   (United States)

^r UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Appropriateness criteria; cancer staging; CT; FDG PET; MRI; ovarian cancer

Indexed keywords

CA 125 ANTIGEN; FLUORODEOXYGLUCOSE F 18; IODINATED CONTRAST MEDIUM;

ARTICLE; CANCER RISK; CANCER SCINTISCANNING; CANCER SCREENING; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CYTOREDUCTIVE SURGERY; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; EARLY CANCER; ENDOMETRIOSIS; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FOLLOW UP; HUMAN; OVARY ADENOCARCINOMA; OVARY CANCER; OVARY CARCINOMA; OVARY CYST; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PROTEIN BLOOD LEVEL; RECURRENT CANCER; TERATOMA; TRANSVAGINAL ECHOGRAPHY;

APPROPRIATENESS CRITERIA; CANCER STAGING; CT; FDG-PET; MRI; OVARIAN CANCER;

DIAGNOSTIC IMAGING; EVIDENCE-BASED MEDICINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MEDICAL ONCOLOGY; NEOPLASM STAGING; OVARIAN NEOPLASMS; RADIOLOGY; UNITED STATES;

EID: 84887154611     PISSN: 15461440     EISSN: 1558349X     Source Type: Journal    
DOI: 10.1016/j.jacr.2013.07.017     Document Type: Article

References (68)

1. American Cancer Society Cancer Facts & Figures 2011 2011 American Cancer Society Atlanta
2. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
3. A. Gadducci, L. Fuso, S. Cosio et al. Are surveillance procedures of clinical benefit for patients treated for ovarian cancer?: A retrospective Italian multicentric study Int J Gynecol Cancer 19 2009 367 374
4. A.M. Lutz, J.K. Willmann, C.W. Drescher et al. Early diagnosis of ovarian carcinoma: is a solution in sight? Radiology 259 2011 329 345
5. S.H. Chandrashekhara, S. Thulkar, D.N. Srivastava et al. Pre-operative evaluation of peritoneal deposits using multidetector computed tomography in ovarian cancer Br J Radiol 84 2011 38 43
6. Y.Y. Jeong, E.K. Outwater, H.K. Kang Imaging evaluation of ovarian masses Radiographics 20 2000 1445 1470
7. S.E. Jung, J.M. Lee, S.E. Rha, J.Y. Byun, J.I. Jung, S.T. Hahn CT and MR imaging of ovarian tumors with emphasis on differential diagnosis Radiographics 22 2002 1305 1325
8. J. Liu, Y. Xu, J. Wang Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis of ovarian carcinoma Eur J Radiol 62 2007 328 334 (Pubitemid 46783368)
9. N.B. Rettenmaier, C.R. Rettenmaier, T. Wojciechowski et al. The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary peritoneal carcinoma: a 16-year institutional review Br J Cancer 103 2010 1657 1662
10. H. Son, S.M. Khan, J. Rahaman et al. Role of FDG PET/CT in staging of recurrent ovarian cancer Radiographics 31 2011 569 583
11. D.S. Chi, J.N. Barlin, P.T. Ramirez et al. Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease of 1 cm or smaller Int J Gynecol Cancer 20 2010 353 357
12. S. Risum, C. Hogdall, A. Loft et al. Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography-a prospective study Gynecol Oncol 108 2008 265 270 (Pubitemid 351181445)
13. R. Forstner, H. Hricak, K.A. Occhipinti, C.B. Powell, S.D. Frankel, J.L. Stern Ovarian cancer: staging with CT and MR imaging Radiology 197 1995 619 626
14. K. Kinkel, H. Hricak, Y. Lu, K. Tsuda, R.A. Filly US characterization of ovarian masses: a meta-analysis Radiology 217 2000 803 811
15. D.M. Twickler, E. Moschos Ultrasound and assessment of ovarian cancer risk AJR Am J Roentgenol 194 2010 322 329
16. F.R. Ueland, P.D. DePriest, E.J. Pavlik, R.J. Kryscio, J.R. van Nagell Jr. Preoperative differentiation of malignant from benign ovarian tumors: the efficacy of morphology indexing and Doppler flow sonography Gynecol Oncol 91 2003 46 50 (Pubitemid 37188592)
17. J.R. van Nagell Jr., P.D. DePriest, F.R. Ueland et al. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened Cancer 109 2007 1887 1896 (Pubitemid 46668555)
18. J. Yazbek, L. Ameye, A.C. Testa et al. Confidence of expert ultrasound operators in making a diagnosis of adnexal tumor: effect on diagnostic accuracy and interobserver agreement Ultrasound Obstet Gynecol 35 2010 89 93
19. J. Yazbek, S.K. Raju, J. Ben-Nagi, T.K. Holland, K. Hillaby, D. Jurkovic Effect of quality of gynaecological ultrasonography on management of patients with suspected ovarian cancer: a randomised controlled trial Lancet Oncol 9 2008 124 131
20. C. Conway, I. Zalud, M. Dilena et al. Simple cyst in the postmenopausal patient: detection and management J Ultrasound Med 17 1998 369 372 quiz 73-4 (Pubitemid 28247239)
21. R.N. Low, C.P. Sebrechts, R.M. Barone, W. Muller Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings-a feasibility study AJR Am J Roentgenol 193 2009 461 470
22. E.J. Nam, M.J. Yun, Y.T. Oh et al. Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI Gynecol Oncol 116 2010 389 394
23. A. Rieber, K. Nussle, I. Stohr et al. Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings AJR Am J Roentgenol 177 2001 123 129 (Pubitemid 32578064)
24. A. Fagotti, F. Fanfani, C. Rossitto et al. A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy Oncology 75 2008 152 158
25. K. Kitajima, K. Murakami, E. Yamasaki et al. Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT Eur J Nucl Med Mol Imaging 35 2008 1912 1920
26. C. Pfannenberg, I. Konigsrainer, P. Aschoff et al. (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Ann Surg Oncol 16 2009 1295 1303
27. S. Risum, C. Hogdall, A. Loft et al. Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer? Gynecol Oncol 116 2010 395 398
28. O. Akin, E. Sala, C.S. Moskowitz et al. Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion Radiology 248 2008 511 517
29. V. Kolev, S. Mironov, O. Mironov et al. Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer Int J Gynecol Cancer 20 2010 979 984
30. I. Thomassin-Naggara, M. Bazot, E. Darai, P. Callard, J. Thomassin, C.A. Cuenod Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis Radiology 248 2008 148 159
31. J.N. Buy, M.A. Ghossain, C. Sciot et al. Epithelial tumors of the ovary: CT findings and correlation with US Radiology 178 1991 811 818
32. M.A. Ghossain, J.N. Buy, C. Ligneres et al. Epithelial tumors of the ovary: comparison of MR and CT findings Radiology 181 1991 863 870
33. R.C. Semelka, P.H. Lawrence, J.P. Shoenut, M. Heywood, M.A. Kroeker, R. Lotocki Primary ovarian cancer: prospective comparison of contrast-enhanced CT and pre-and postcontrast, fat-suppressed MR imaging, with histologic correlation J Magn Reson Imaging 3 1993 99 106
34. A. Qayyum, F.V. Coakley, A.C. Westphalen, H. Hricak, W.T. Okuno, B. Powell Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer Gynecol Oncol 96 2005 301 306 (Pubitemid 40127125)
35. J.Y. Hou, M.G. Kelly, H. Yu et al. Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease Gynecol Oncol 105 2007 211 217 (Pubitemid 46441463)
36. S. Tangjitgamol, S. Manusirivithaya, M. Laopaiboon, P. Lumbiganon Interval debulking surgery for advanced epithelial ovarian cancer: a Cochrane systematic review Gynecol Oncol 112 2009 257 264
37. B. Lund, K. Jacobsen, L. Rasch, F. Jensen, K. Olesen, K. Feldt-Rasmussen Correlation of abdominal ultrasound and computed tomography scans with second- or third-look laparotomy in patients with ovarian carcinoma Gynecol Oncol 37 1990 279 283 (Pubitemid 20182295)
38. J.I. Meyer, A.W. Kennedy, R. Friedman, A. Ayoub, R.C. Zepp Ovarian carcinoma: value of CT in predicting success of debulking surgery AJR Am J Roentgenol 165 1995 875 878
39. B.E. Nelson, A.T. Rosenfield, P.E. Schwartz Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma J Clin Oncol 11 1993 166 172 (Pubitemid 23059991)
40. H.K. Pannu, K.M. Horton, E.K. Fishman Thin section dual-phase multidetector-row computed tomography detection of peritoneal metastases in gynecologic cancers J Comput Assist Tomogr 27 2003 333 340 (Pubitemid 36798083)
41. N. Griffin, L.A. Grant, S.J. Freeman et al. Image-guided biopsy in patients with suspected ovarian carcinoma: a safe and effective technique? Eur Radiol 19 2009 230 235
42. M.J. Hewitt, K. Anderson, G.D. Hall et al. Women with peritoneal carcinomatosis of unknown origin: Efficacy of image-guided biopsy to determine site-specific diagnosis BJOG 114 2007 46 50 (Pubitemid 44923931)
43. F.F. Souza, K.J. Mortele, E.S. Cibas, S.M. Erturk, S.G. Silverman Predictive value of percutaneous imaging-guided biopsy of peritoneal and omental masses: results in 111 patients AJR Am J Roentgenol 192 2009 131 136
44. J.A. Spencer, M.J. Weston, S.A. Saidi, N. Wilkinson, G.D. Hall Clinical utility of image-guided peritoneal and omental biopsy Nat Rev Clin Oncol 7 2010 623 631
45. S. Cohen-Mouly, A. Badia, A.S. Bats et al. Role of video-assisted thoracoscopy in patients with ovarian cancer and pleural effusion Int J Gynecol Cancer 19 2009 1662 1665
46. O. Mironov, N.M. Ishill, S. Mironov et al. Pleural effusion detected at CT prior to primary cytoreduction for stage III or IV ovarian carcinoma: effect on survival Radiology 258 2011 776 784
47. A.H. Dachman, A. Visweswaran, R. Battula, S. Jameel, S.E. Waggoner Role of chest CT in the follow-up of ovarian adenocarcinoma AJR Am J Roentgenol 176 2001 701 705 (Pubitemid 32181969)
48. T. Sella, E. Rosenbaum, D.Z. Edelmann, R. Agid, A.I. Bloom, E. Libson Value of chest CT scans in routine ovarian carcinoma follow-up AJR Am J Roentgenol 177 2001 857 859 (Pubitemid 32881664)
49. H. Hricak, M. Chen, F.V. Coakley et al. Complex adnexal masses: detection and characterization with MR imaging-multivariate analysis Radiology 214 2000 39 46 (Pubitemid 30019867)
50. S. Mironov, O. Akin, N. Pandit-Taskar, L.E. Hann Ovarian cancer Radiol Clin North Am 45 2007 149 166 (Pubitemid 44854050)
51. P.J. Woodward, K. Hosseinzadeh, J.S. Saenger From the archives of the AFIP: radiologic staging of ovarian carcinoma with pathologic correlation Radiographics 24 2004 225 246 (Pubitemid 38134607)
52. S.J. Booth, L.W. Turnbull, D.R. Poole, I. Richmond The accurate staging of ovarian cancer using 3T magnetic resonance imaging-a realistic option BJOG 115 2008 894 901 (Pubitemid 351692995)
53. A.E. Axtell, M.H. Lee, R.E. Bristow et al. Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer J Clin Oncol 25 2007 384 389 (Pubitemid 350002986)
54. A.J. Megibow, M.A. Bosniak, A.G. Ho, U. Beller, D.H. Hulnick, E.M. Beckman Accuracy of CT in detection of persistent or recurrent ovarian carcinoma: correlation with second-look laparotomy Radiology 166 1988 341 345 (Pubitemid 18030736)
55. K.L. Reuter, T. Griffin, R.E. Hunter Comparison of abdominopelvic computed tomography results and findings at second-look laparotomy in ovarian carcinoma patients Cancer 63 1989 1123 1128 (Pubitemid 19074742)
56. P.M. Silverman, M. Osborne, N.R. Dunnick, L.C. Bandy CT prior to second-look operation in ovarian cancer AJR Am J Roentgenol 150 1988 829 832 (Pubitemid 18088258)
57. P. Castellucci, A.M. Perrone, M. Picchio et al. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology Nucl Med Commun 28 2007 589 595 (Pubitemid 47067045)
58. S. Fenchel, D. Grab, K. Nuessle et al. Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings Radiology 223 2002 780 788 (Pubitemid 34547598)
59. S. Sebastian, S.I. Lee, N.S. Horowitz et al. PET-CT vs. CT alone in ovarian cancer recurrence Abdom Imaging 33 2008 112 118
60. M. Murakami, T. Miyamoto, T. Iida et al. Whole-body positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer Int J Gynecol Cancer 16 Suppl 1 2006 99 107
61. Y. Yoshida, T. Kurokawa, K. Kawahara et al. Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer AJR Am J Roentgenol 182 2004 227 233 (Pubitemid 38017747)
62. Y. Nakamoto, T. Saga, T. Ishimori et al. Clinical value of positron emission tomography with FDG for recurrent ovarian cancer AJR Am J Roentgenol 176 2001 1449 1454 (Pubitemid 32510262)
63. M.M. Thrall, J.A. DeLoia, H. Gallion, N. Avril Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer Gynecol Oncol 105 2007 17 22 (Pubitemid 46441448)
64. N.S. Azad, C.M. Annunziata, S.M. Steinberg et al. Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy Cancer 112 2008 1726 1732 (Pubitemid 351536832)
65. H.S. Kim, J.W. Kim, J.Y. Cho et al. The role of serum CA-125 levels in early-stage epithelial ovarian cancer on preoperative CT and MRI Eur J Surg Oncol 35 2009 870 876
66. I. Jacobs, A.P. Davies, J. Bridges et al. Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography BMJ 306 1993 1030 1034 (Pubitemid 23105960)
67. ACR. Manual on Contrast Media. Available at: http://www.acr.org/Quality- Safety/Resources/Contrast-Manual.
68. ACR. ACR Appropriateness Criteria: radiation dose assessment introduction. Available at: http://www.acr.org/∼/media/ACR/Documents/ AppCriteria/RRLInformation.pdf. Accessed July 11, 2013.